Historical record - last NADAC publication: 7/20/2016
Product Information
MORPHINE SULFATE ER 90 MG CAP is a generic product labeled by Actavis Pharma, Inc., priced at $13.9076 per EA under NDC 00228309211. Its NADAC has been published 140 times since Dec 17, 2014.
The High Outlier badge above means this manufacturer's average price in the Morphine sulfate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
90 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00228309211
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
7/20/2016
Active Ingredients
MORPHINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA079040On Market Since
2/4/2014
Pharmacological Classes
Price Statistics
The NADAC for MORPHINE SULFATE ER 90 MG CAP has been published 140 times since Dec 17, 2014, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $13.9076 per EA |
|---|---|
| All-time high | $14.8110 (Jul 13, 2016) |
| All-time low | $13.0323 (Mar 18, 2015) |
| Median price | $13.9076 |
| Average price | $13.8017 |
| Largest weekly change | +9.3% (Jun 22, 2016) |
| Weeks tracked | 140 |
| Tracking since | Dec 17, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Morphine sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of MORPHINE SULFATE ER 90 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for MORPHINE SULFATE ER 90 MG CAP, manufactured by Actavis Pharma, Inc., is $13.9076 per EA (NDC 00228309211), effective Aug 16, 2017.
How has the price of MORPHINE SULFATE ER 90 MG CAP changed over time?
Over the history we have for it, the NADAC for MORPHINE SULFATE ER 90 MG CAP has held within roughly two percent of its current level. It has been tracked across 140 weekly CMS publications since Dec 17, 2014.
What are the highest and lowest recorded NADAC prices for MORPHINE SULFATE ER 90 MG CAP?
Since Dec 17, 2014, the NADAC for MORPHINE SULFATE ER 90 MG CAP has ranged from a low of $13.0323 (Mar 18, 2015) to a high of $14.8110 (Jul 13, 2016), with a median of $13.9076 per EA.
Are there cheaper alternatives to MORPHINE SULFATE ER 90 MG CAP?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of MORPHINE SULFATE ER 90 MG CAP, so no direct lower-cost alternative is listed.
Who manufactures MORPHINE SULFATE ER 90 MG CAP?
MORPHINE SULFATE ER 90 MG CAP (NDC 00228309211) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification